The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion
Open accessAbstract
T cells target peptide combos: One of the enduring mysteries of autoimmunity is the identity of the specific proteins targeted by autoimmune T cells. Delong et al. used mass spectrometry to elucidate the peptide targets of autoimmune T cells isolated from a mouse model of type 1 diabetes. T cells targeted hybrid peptides formed by the covalent linking of a peptide derived from pro-insulin to other peptides derived from proteins found in pancreatic beta cells. T cells isolated from the pancreatic islets of two individuals with type 1 diabetes also recognized such hybrid peptides, suggesting that they may play an important role in driving disease. Science , this issue p. 711
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus
Todd, J. A., Bell, J. I., & McDevitt, H. O. (1987) · Nature · doi:10.1038/329599a0 · Cited by 2,036
Automated Method for Isolation of Human Pancreatic Islets
Ricordi, C., Lacy, P. E., Finke, E. H., Olack, B. J., & Scharp, D. W. (1988) · Diabetes · doi:10.2337/diab.37.4.413 · Cited by 1,310
Zero-length crosslinking procedure with the use of active esters
Grabarek, Z., & Gergely, J. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90267-d · Cited by 827
Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice
Nakayama, M., Abiru, N., Moriyama, H., Babaya, N., Liu, E., Miao, D., Yu, L., Wegmann, D. R., Hutton, J. C., Elliott, J. F., et al. (2005) · Nature · doi:10.1038/nature03523 · Cited by 758
The NOD mouse model of type 1 diabetes: As good as it gets?
Atkinson, M. A., & Leiter, E. H. (1999) · Nature Medicine · doi:10.1038/9442 · Cited by 588
Chromogranin A is an autoantigen in type 1 diabetes
Stadinski, B. D., Delong, T., Reisdorph, N., Reisdorph, R., Powell, R. L., Armstrong, M., Piganelli, J. D., Barbour, G., Bradley, B., Crawford, F., et al. (2010) · Nature Immunology · doi:10.1038/ni.1844 · Cited by 338
Self-citationImmune recognition of a human renal cancer antigen through post-translational protein splicing
Hanada, K.-I., Yewdell, J. W., & Yang, J. C. (2004) · Nature · doi:10.1038/nature02240 · Cited by 336
An Antigenic Peptide Produced by Peptide Splicing in the Proteasome
Vigneron, N., Stroobant, V., Chapiro, J., Ooms, A., Degiovanni, G., Morel, S., van der Bruggen, P., Boon, T., & Van den Eynde, B. J. (2004) · Science · doi:10.1126/science.1095522 · Cited by 330
The insulin A-chain epitope recognized by human T cells is posttranslationally modified
Mannering, S. I., Harrison, L. C., Williamson, N. A., Morris, J. S., Thearle, D. J., Jensen, K. P., Kay, T. W. H., Rossjohn, J., Falk, B. A., Nepom, G. T., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051251 · Cited by 231
Self-citationAn Antigen Produced by Splicing of Noncontiguous Peptides in the Reverse Order
Warren, E. H., Vigneron, N. J., Gavin, M. A., Coulie, P. G., Stroobant, V., Dalet, A., Tykodi, S. S., Xuereb, S. M., Mito, J. K., Riddell, S. R., et al. (2006) · Science · doi:10.1126/science.1130660 · Cited by 201
Posttranslational Modification of HLA-DQ Binding Islet Autoantigens in Type 1 Diabetes
van Lummel, M., Duinkerken, G., van Veelen, P. A., de Ru, A., Cordfunke, R., Zaldumbide, A., Gomez-Touriño, I., Arif, S., Peakman, M., Drijfhout, J. W., et al. (2014) · Diabetes · doi:10.2337/db12-1214 · Cited by 195
Pathiraja, V., Kuehlich, J. P., Campbell, P. D., Krishnamurthy, B., Loudovaris, T., Coates, P. T. H., Brodnicki, T. C., O’Connell, P. J., Kedzierska, K., Rodda, C., et al. (2015) · Diabetes · doi:10.2337/db14-0858 · Cited by 165
Self-citationAutoantigenesis: the evolution of protein modifications in autoimmune disease
Doyle, H. A., & Mamula, M. J. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.12.003 · Cited by 149
Recognition of Posttranslationally Modified GAD65 Epitopes in Subjects With Type 1 Diabetes
McGinty, J. W., Chow, I.-T., Greenbaum, C., Odegard, J., Kwok, W., & James, E. (2014) · Diabetes · doi:10.2337/db13-1952 · Cited by 143
Nepom, G. T. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102398 · Cited by 118
Diabetogenic T-Cell Clones Recognize an Altered Peptide of Chromogranin A
Delong, T., Baker, R. L., He, J., Barbour, G., Bradley, B., & HASKINS, K. M. (2012) · Diabetes · doi:10.2337/db12-0112 · Cited by 113
Self-citationSusceptible MHC alleles, not background genes, select an autoimmune T cell reactivity
Stratmann, T., Martín‐Orozco, N., Mallet-Designe, V., Poirot, L., McGavern, D. B., Losyev, G., Dobbs, C. M., Oldstone, M. B. A., YOSHIDA, K., Kikutani, H., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18337 · Cited by 96
Self-citationPathogenic T‐Cell Clones in Autoimmune Diabetes: More Lessons from the NOD Mouse
HASKINS, K. M. (2005) · Advances in immunology · doi:10.1016/s0065-2776(05)87004-x · Cited by 84
Self-citationChromogranin A is a T cell antigen in human type 1 diabetes
Gottlieb, P. A., Delong, T., Baker, R. L., Fitzgerald-Miller, L., Wagner, R., Cook, G., Rewers, M., Michels, A. W., & HASKINS, K. M. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.10.003 · Cited by 80
Self-citationSuitability of human juvenile pancreatic islets for clinical use
Balamurugan, A. N., Chang, Y., Bertera, S., Sands, A., Shankar, V., Trucco, M., & Bottino, R. (2006) · Diabetologia · doi:10.1007/s00125-006-0318-0 · Cited by 71
Self-citationIslet Amyloid Polypeptide Is a Target Antigen for Diabetogenic CD4+ T Cells
Delong, T., Baker, R., Reisdorph, N., Reisdorph, R., Powell, R., Armstrong, M., Barbour, G., Bradley, B., & Haskins, K. (2011) · Diabetes · doi:10.2337/db11-0288 · Cited by 60
Self-citationHigham, C., Hull, R. L., Lawrie, L. C., SHENNAN, K. I. J., Morris, J. F., Birch, N. P., Docherty, K., & Clark, A. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01548.x · Cited by 55
Baker, R. L., Delong, T., Barbour, G., Bradley, B., Nakayama, M., & HASKINS, K. M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301480 · Cited by 40
Self-citationVolume Exclusion Effect as a Driving Force for Reverse Proteolysis
Somalinga, B. R., & Roy, R. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207974200 · Cited by 36
Chang, K. Y., & Unanue, E. R. (2009) · International Immunology · doi:10.1093/intimm/dxp039 · Cited by 30
Cited by
Katsarou, A., Gudbjörnsdottir, S., Rawshani, A., Dabelea, D., Bonifacio, E., Anderson, B. J., Jacobsen, L. M., Schatz, D. A., & Lernmark, Å. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.16 · Cited by 1,475
Cancer vaccines: the next immunotherapy frontier
Lin, M. J., Svensson-Arvelund, J., Lubitz, G. S., Marabelle, A., Melero, I., Brown, B. D., & Brody, J. D. (2022) · Nature Cancer · doi:10.1038/s43018-022-00418-6 · Cited by 843
Dendrou, C. A., Petersen, J., Rossjohn, J., & Fugger, L. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.143 · Cited by 787
Environmental risk factors for type 1 diabetes
Rewers, M., & Ludvigsson, J. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30507-4 · Cited by 676
Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?)
Roep, B. O., Thomaidou, S., van Tienhoven, R., & Zaldumbide, A. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00443-4 · Cited by 623
Metadata
- Authors
- Delong, T., Wiles, T. A., Baker, R. L., Bradley, B., Barbour, G., Reisdorph, R., Armstrong, M., Powell, R. L., Reisdorph, N., Kumar, N., Elso, C. M., DeNicola, M., Bottino, R., Powers, A. C., Harlan, D. M., Kent, S. C., Mannering, S. I., & Haskins, K.
- Venue
- Science
- Published
- 2016-02-12
- Volume
- 351
- Issue
- 6274
- Pages
- 711-714
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2266478788
- Cited by
- 503
- References
- 25
- FWCI
- 48.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.